Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Richard G Everson, Michael W Graner, Matthias Gromeier, James J Vredenburgh, Annick Desjardins, David A Reardon, Henry S Friedman, Allan H Friedman, Darell D Bigner & John H Sampson. (2008) Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Expert Review of Anticancer Therapy 8:5, pages 717-732.
Read now
Read now
Chryso Kanthou & Gillian M Tozer. (2007) Tumour targeting by microtubule-depolymerising vascular disrupting agents. Expert Opinion on Therapeutic Targets 11:11, pages 1443-1457.
Read now
Read now
Grzegorz Burnat, Tilman Rau, Esam Elshimi, Eckhart Georg Hahn & Peter Christopher Konturek. (2007) Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line. Scandinavian Journal of Gastroenterology 42:12, pages 1460-1465.
Read now
Read now
Articles from other publishers (30)
Xuemei Ji, Hongyan Wang, Yue Chen, Junfei Zhou & Yu Liu. (2019) Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma. AMB Express 9:1.
Crossref
Crossref
Vito Giuseppe D’Agostino, Denise Sighel, Chiara Zucal, Isabelle Bonomo, Mariachiara Micaelli, Graziano Lolli, Alessandro Provenzani, Alessandro Quattrone & Valentina Adami. (2019) Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery. SLAS Discovery 24:3, pages 314-331.
Crossref
Crossref
Barbara J. Bałan, Andrzej K. Siwicki, Krzysztof Pastewka, Urszula Demkow, Piotr Skopiński, Ewa Skopińska-Różewska, Sławomir Lewicki & Robert Zdanowski. 2017. Clinical Research and Practice. Clinical Research and Practice
91
104
.
Hae Ryung Chang, Hee Seo Park, Young Zoo Ahn, Seungyoon Nam, Hae Rim Jung, Sungjin Park, Sang Jin Lee, Curt Balch, Garth Powis, Ja-Lok Ku & Yon Hui Kim. (2016) Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems. BMC Cancer 16:1.
Crossref
Crossref
Jing Chen, Shu Zhu, Liangqian Tong, Jiansha Li, Fei Chen, Yunfeng Han, Ming Zhao & Wei Xiong. (2014) Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice. BMC Cancer 14:1.
Crossref
Crossref
Linghui NieOrestis Lyros, Rituparna MeddaNebojsa Jovanovic, Jamie L. Schmidt, Mary F. OttersonChristopher P. JohnsonBehnaz Behmaram, Reza Shaker & Parvaneh Rafiee. (2014) Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. American Journal of Physiology-Cell Physiology 307:9, pages C859-C877.
Crossref
Crossref
Jean-Pierre Droz, Jaques Medioni, Christine Chevreau, Helene De Mont-Serrat, Michael Merger, Peter Stopfer, Rolf Kaiser & Stephane Oudard. (2014) Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel. Anti-Cancer Drugs 25:9, pages 1081-1088.
Crossref
Crossref
Nali Zhang, Guojun Zhang, Youguang Zheng, Tongbing Wang & Honglei Wang. (2014) Effect of Avastin on the number and structure of tumor blood vessels of nude mice with A549 lung adenocarcinoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
Qun Shu, Wenjiao Li, Haichuan Li & Gang Sun. (2014) Vasostatin Inhibits VEGF-Induced Endothelial Cell Proliferation, Tube Formation and Induces Cell Apoptosis under Oxygen Deprivation. International Journal of Molecular Sciences 15:4, pages 6019-6030.
Crossref
Crossref
Li Sun, Da-hai Yu, San-Yuan Sun, Shi-Chao Zhuo, Su-sheng Cao & Ling Wei. (2013) Expressions of ER, PR, HER-2, COX-2, and VEGF in Primary and Relapsed/Metastatic Breast Cancers. Cell Biochemistry and Biophysics 68:3, pages 511-516.
Crossref
Crossref
Wei Luo, Qiang Hu, Dan Wang, Kristin K. Deeb, Yingyu Ma, Carl D. Morrison, Song Liu, Candace S. Johnson & Donald L. Trump. (2013) Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue. Oncotarget 4:9, pages 1472-1483.
Crossref
Crossref
Céline Schmitt, Manon Voegelin, Aurélie Marin, Marjorie Schmitt, Fabienne Schegg, Philippe Hénon, Dominique Guenot & Céline Tarnus. (2013) Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Bioorganic & Medicinal Chemistry 21:7, pages 2135-2144.
Crossref
Crossref
Koji Kishimoto, Shoko Yoshida, Soichiro Ibaragi, Norie Yoshioka, Tatsuo Okui, Guo-fu Hu & Akira Sasaki. (2012) Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer. Oral Oncology 48:11, pages 1120-1127.
Crossref
Crossref
Terence F. McGuire, Gangadharan B. Sajithlal, Jie Lu, Robert D. Nicholls & Edward V. Prochownik. (2012) In Vivo Evolution of Tumor-Derived Endothelial Cells. PLoS ONE 7:5, pages e37138.
Crossref
Crossref
Yi-Hong Kwon, Seok-Yun Jung, Jae-Won Kim, Sang-Hun Lee, Jun-Hee Lee, Boo-Yong Lee & Sang-Mo Kwon. (2012) Phloroglucinol Inhibits the Bioactivities of Endothelial Progenitor Cells and Suppresses Tumor Angiogenesis in LLC-Tumor-Bearing Mice. PLoS ONE 7:4, pages e33618.
Crossref
Crossref
Deana Marshall, Duane A. Mitchell, Michael W. Graner & Darell D. Bigner. 2012. Neuro-Oncology. Vol 104 HCN Series. Neuro-Oncology. Vol 104 HCN Series
309
330
.
Christel Vangestel, Christophe Van de Wiele, Nancy Van Damme, Steven Staelens, Patrick Pauwels, Chris P.M. Reutelingsperger & Marc Peeters. (2011)
99m
Tc-(CO)
3
His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab
. Journal of Nuclear Medicine 52:11, pages 1786-1794.
Crossref
Crossref
JUNG YEON KIM, BYUNG-NOE BAE, JI EUN KWON, HYUN-JUNG KIM & KYEONGMEE PARK. (2011) Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma. APMIS 119:7, pages 449-459.
Crossref
Crossref
Rui Xu, Kenji Nakano, Hironori Iwasaki, Michiaki Kumagai, Rie Wakabayashi, Akio Yamasaki, Hiroyuki Suzuki, Ryuichi Mibu, Hideya Onishi & Mitsuo Katano. (2011) Dual blockade of phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer. Cancer Letters 306:2, pages 151-160.
Crossref
Crossref
Raffaella Rossin. 2011. Nanoplatform‐Based Molecular Imaging. Nanoplatform‐Based Molecular Imaging
399
429
.
Inga J. Duignan, Erik Corcoran, Anthony Pennello, Mary Jane Plym, Michael Amatulli, Nidia Claros, Michelle Iacolina, Hagop Youssoufian, Larry Witte, Selda Samakoglu, Jonathan Schwartz, David Surguladze & James R. Tonra. (2011) Pleiotropic Stromal Effects of Vascular Endothelial Growth Factor Receptor 2 Antibody Therapy in Renal Cell Carcinoma Models. Neoplasia 13:1, pages 49-59.
Crossref
Crossref
Laura A. Sullivan, Juliet G. Carbon, Christina L. Roland, Jason E. Toombs, Mari Nyquist-Andersen, Anita Kavlie, Kyle Schlunegger, James A. Richardson & Rolf A. Brekken. (2010) r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction. PLoS ONE 5:8, pages e12031.
Crossref
Crossref
Hamidreza Aliabadi, James J. Vredenburgh, Richard G. Everson, Annick Desjardins, Henry S. Friedman, Roger E. McLendon, Debara L. Tucci & John H. Sampson. (2009) Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration. Journal of Neuro-Oncology 98:3, pages 427-430.
Crossref
Crossref
Michael L. Maitland, Xing Jian Lou, Jacqueline Ramirez, Apurva A. Desai, Dorit S. Berlin, Howard L. McLeod, Ralph R. Weichselbaum, Mark J. Ratain, Russ B. Altman & Teri E. Klein. (2010) Vascular endothelial growth factor pathway. Pharmacogenetics and Genomics 20:5, pages 346-349.
Crossref
Crossref
Gerald W. Prager, Eva-Maria Lackner, Maria-Theresa Krauth, Matthias Unseld, Marina Poettler, Sylvia Laffer, Sabine Cerny-Reiterer, Wolfgang Lamm, Gabriela V. Kornek, Bernd R. Binder, Christoph C. Zielinski & Peter Valent. (2010) Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. Molecular Oncology 4:2, pages 150-160.
Crossref
Crossref
Curtis J. Wray, Ami N. Shah, Russell S. Berman & Syed A. Ahmad. 2009. Liver Metastases. Liver Metastases
1
10
.
James R. Tonra, Marie Prewett, Erik Corcoran, Daniel J. Hicklin & Zhenping Zhu. 2009. Therapeutic Antibodies. Therapeutic Antibodies
545
557
.
Esther Raskopf, Annabelle Vogt, Tilman Sauerbruch & Volker Schmitz. (2008) siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. Journal of Hepatology 49:6, pages 977-984.
Crossref
Crossref
Y. LIU, L. CHEN, X. HE, L. FAN, G. YANG, X. CHEN, X. LIN, L. DU, Z. LI, H. YE, Y. MAO, X. ZHAO & Y. WEI. (2008) Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma. International Journal of Gynecological Cancer 18:4, pages 652-659.
Crossref
Crossref
Duane A. Mitchell, Peter E. Fecci & John H. Sampson. (2008) Immunotherapy of malignant brain tumors. Immunological Reviews 222:1, pages 70-100.
Crossref
Crossref